BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 23751564)

  • 1. Colon cancer mesenchymal stem cells modulate the tumorigenicity of colon cancer through interleukin 6.
    Lin JT; Wang JY; Chen MK; Chen HC; Chang TH; Su BW; Chang PJ
    Exp Cell Res; 2013 Aug; 319(14):2216-29. PubMed ID: 23751564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stroma-directed imatinib therapy impairs the tumor-promoting effect of bone marrow-derived mesenchymal stem cells in an orthotopic transplantation model of colon cancer.
    Shinagawa K; Kitadai Y; Tanaka M; Sumida T; Onoyama M; Ohnishi M; Ohara E; Higashi Y; Tanaka S; Yasui W; Chayama K
    Int J Cancer; 2013 Feb; 132(4):813-23. PubMed ID: 22821812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maintenance of the stemness in CD44(+) HCT-15 and HCT-116 human colon cancer cells requires miR-203 suppression.
    Ju SY; Chiou SH; Su Y
    Stem Cell Res; 2014 Jan; 12(1):86-100. PubMed ID: 24145190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recruited brain tumor-derived mesenchymal stem cells contribute to brain tumor progression.
    Behnan J; Isakson P; Joel M; Cilio C; Langmoen IA; Vik-Mo EO; Badn W
    Stem Cells; 2014 May; 32(5):1110-23. PubMed ID: 24302539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro expanded bone marrow-derived murine (C57Bl/KaLwRij) mesenchymal stem cells can acquire CD34 expression and induce sarcoma formation in vivo.
    Xu S; De Becker A; De Raeve H; Van Camp B; Vanderkerken K; Van Riet I
    Biochem Biophys Res Commun; 2012 Aug; 424(3):391-7. PubMed ID: 22771324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer stem-like cell marker CD44 promotes bone metastases by enhancing tumorigenicity, cell motility, and hyaluronan production.
    Hiraga T; Ito S; Nakamura H
    Cancer Res; 2013 Jul; 73(13):4112-22. PubMed ID: 23633482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocellular carcinoma cells and their fibrotic microenvironment modulate bone marrow-derived mesenchymal stromal cell migration in vitro and in vivo.
    Garcia MG; Bayo J; Bolontrade MF; Sganga L; Malvicini M; Alaniz L; Aquino JB; Fiore E; Rizzo MM; Rodriguez A; Lorenti A; Andriani O; Podhajcer O; Mazzolini G
    Mol Pharm; 2011 Oct; 8(5):1538-48. PubMed ID: 21770423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA expression profile of colon cancer stem-like cells in HT29 adenocarcinoma cell line.
    Zhang H; Li W; Nan F; Ren F; Wang H; Xu Y; Zhang F
    Biochem Biophys Res Commun; 2011 Jan; 404(1):273-8. PubMed ID: 21130073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal stem cell-derived interleukin-6 and vascular endothelial growth factor promote breast cancer cell migration.
    De Luca A; Lamura L; Gallo M; Maffia V; Normanno N
    J Cell Biochem; 2012 Nov; 113(11):3363-70. PubMed ID: 22644871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal stem cell-like cells from children foreskin inhibit the growth of SGC-7901 gastric cancer cells.
    Li Y; Zhao Y; Cheng Z; Zhan J; Sun X; Qian H; Zhu W; Xu W
    Exp Mol Pathol; 2013 Jun; 94(3):430-7. PubMed ID: 23421973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. STAT3 activation by IL-6 from mesenchymal stem cells promotes the proliferation and metastasis of osteosarcoma.
    Tu B; Du L; Fan QM; Tang Z; Tang TT
    Cancer Lett; 2012 Dec; 325(1):80-8. PubMed ID: 22743617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumorigenic hybrids between mesenchymal stem cells and gastric cancer cells enhanced cancer proliferation, migration and stemness.
    Xue J; Zhu Y; Sun Z; Ji R; Zhang X; Xu W; Yuan X; Zhang B; Yan Y; Yin L; Xu H; Zhang L; Zhu W; Qian H
    BMC Cancer; 2015 Oct; 15():793. PubMed ID: 26498753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of mesenchymal stem cell secreted PAI-1 on colon cancer cell migration and proliferation.
    Hogan NM; Joyce MR; Murphy JM; Barry FP; O'Brien T; Kerin MJ; Dwyer RM
    Biochem Biophys Res Commun; 2013 Jun; 435(4):574-9. PubMed ID: 23685140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-8/CXCR2 mediates tropism of human bone marrow-derived mesenchymal stem cells toward CD133
    Ma X; Chen J; Liu J; Xu B; Liang X; Yang X; Feng Y; Liang X; Liu J
    J Cell Physiol; 2021 Apr; 236(4):3114-3128. PubMed ID: 33078417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal stem cells enhance growth and metastasis of colon cancer.
    Shinagawa K; Kitadai Y; Tanaka M; Sumida T; Kodama M; Higashi Y; Tanaka S; Yasui W; Chayama K
    Int J Cancer; 2010 Nov; 127(10):2323-33. PubMed ID: 20473928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of mesenchymal stem cells on metastasis development in mice in vivo.
    Meleshina AV; Cherkasova EI; Shirmanova MV; Klementieva NV; Kiseleva EV; Snopova LВ; Prodanets NN; Zagaynova EV
    Stem Cell Res Ther; 2015 Feb; 6(1):15. PubMed ID: 25888992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of stemness and stem cell niche of mesenchymal stem cells: implications in tumorigenesis and metastasis.
    Kuhn NZ; Tuan RS
    J Cell Physiol; 2010 Feb; 222(2):268-77. PubMed ID: 19847802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of TGF-β/Smad signaling by BAMBI blocks differentiation of human mesenchymal stem cells to carcinoma-associated fibroblasts and abolishes their protumor effects.
    Shangguan L; Ti X; Krause U; Hai B; Zhao Y; Yang Z; Liu F
    Stem Cells; 2012 Dec; 30(12):2810-9. PubMed ID: 23034983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal stem cells seldomly fuse with hepatocellular carcinoma cells and are mainly distributed in the tumor stroma in mouse models.
    Li GC; Ye QH; Dong QZ; Ren N; Jia HL; Qin LX
    Oncol Rep; 2013 Feb; 29(2):713-9. PubMed ID: 23232668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal stem cells from primary breast cancer tissue promote cancer proliferation and enhance mammosphere formation partially via EGF/EGFR/Akt pathway.
    Yan XL; Fu CJ; Chen L; Qin JH; Zeng Q; Yuan HF; Nan X; Chen HX; Zhou JN; Lin YL; Zhang XM; Yu CZ; Yue W; Pei XT
    Breast Cancer Res Treat; 2012 Feb; 132(1):153-64. PubMed ID: 21584665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.